Carolyn Dilanni Carroll

Title: Carolyn Dilanni Carroll: Innovator in Chemokine Mediated Disease Treatment

Introduction

Carolyn Dilanni Carroll is a notable inventor based in Yardley, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target chemokine mediated diseases. Her work has the potential to impact the treatment of various inflammatory and autoimmune conditions.

Latest Patents

Carolyn holds a patent for "Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity." This patent discloses a compound, including its enantiomers, stereoisomers, and other derivatives, which can be used in treating diseases such as psoriasis, rheumatoid arthritis, multiple sclerosis, and more. The compound is designed to provide therapeutic benefits in both palliative and curative therapies.

Career Highlights

Throughout her career, Carolyn has worked with reputable companies, including Schering Corporation and Pharmacopeia Inc. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations and contribute to significant advancements in drug development.

Collaborations

Carolyn has collaborated with notable professionals in her field, including Brian F. McGuinness and Stuart B. Rosenblum. These collaborations have further enriched her research and development efforts, leading to impactful innovations.

Conclusion

Carolyn Dilanni Carroll is a pioneering inventor whose work in the pharmaceutical industry has the potential to transform the treatment landscape for chemokine mediated diseases. Her contributions are invaluable, and her patent reflects her commitment to advancing medical science.